LifeMax

Redwood City, United States Founded: 2014 • Age: 12 yrs
Develops innovative therapeutic solutions for Netherton syndrome treatment.

About LifeMax

LifeMax is a Healthcare company based in Redwood City (United States) founded in 2014. It develops innovative therapeutic solutions for Netherton syndrome treatment. It operates on a B2B model. Its focus areas include Biotechnology, Therapeutics and Rare Diseases. Its competitors include Castle Creek Biosciences and Eicos Sciences; 1 of its 2 listed competitors has raised funding.

Company details

LifeMax develops innovative therapeutic solutions for netherton syndrome treatment, focusing on providing healthcare solutions, advancing biotech innovations, therapeutics, and rare diseases. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets. It continues to evolve, meeting industry challenges with strategic approaches.

  • Headquarters Redwood City, United States
  • Sectors
    Healthcare
  • Website lifemaxlabs.com
Operational Areas

People of LifeMax

6 people are tracked at LifeMax (6 in leadership).

NameRoleGroup
Larry Hsu
Chairman & CEOLeadership
Michael Huang
Chief Medical OfficerLeadership
Laura Zhu
Chief Business OfficerLeadership
Andrew Sauter
Chief Financial OfficerLeadership
Kirk Johnson
Chief Scientific OfficerLeadership
Dorothy Nguyen
Vp, Clinical DevelopmentLeadership
Premium access

Complete people profiles for LifeMax

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Competitors of LifeMax

LifeMax has 2 listed competitors in our database, 1 of them funded. They include Castle Creek Biosciences and Eicos Sciences.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
castlecreekbio.com2018Exton, United States$192.8M41
Gene therapy platform for rare disease treatments is developed.
eicossciences.com2016San Mateo, United States9
Develops Prostacyclin-based therapies for underserved medical conditions globally.
Premium access

Detailed competitors of LifeMax

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Rare Diseases

3 companies that operate in the same segment as LifeMax (Rare Diseases) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
mRNA-based therapeutics for diseases including cancer and infections are developed.
2010Cambridge, Massachusetts, United StatesUSD 2.78 BUSD 1.94 B5,800
Gene therapies for rare diseases including retinal dystrophies are developed.
2013Philadelphia, Pennsylvania, United StatesUSD 82.8 MUSD 64.73 M822
Therapeutics for genetic diseases are developed through targeted interventions.
2015Palo Alto, California, United StatesUSD 434.2 MUSD 502.08 M730
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Lifemax

Premium access

Complete news archive for LifeMax

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about LifeMax

LifeMax was founded in 2014.

LifeMax is headquartered in Redwood City, United States. It is registered at Redwood City, California, United States.

LifeMax develops innovative therapeutic solutions for netherton syndrome treatment, focusing on providing healthcare solutions, advancing biotech innovations, therapeutics, and rare diseases. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets. It continues to evolve, meeting industry challenges with strategic approaches.

LifeMax's top competitors include Castle Creek Biosciences and Eicos Sciences.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available